EDRE
BIIB icon

Edmond de Rothschild (Europe)’s Biogen BIIB Stock Holding History

Edmond de Rothschild (Europe)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-250
Closed -$77K – 237
2015
Q4 		$77K Hold
250
– – 0.03% 158
2015
Q3 		$73K Hold
250
– – 0.03% 165
2015
Q2 		$101K Buy
+250
New +$100K 0.03% 179

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Edmond de Rothschild (Europe)'s BIIB Position: Q1 2016 in Review

Edmond de Rothschild (Europe) sold out of Biogen (BIIB) in Q1 2016, closing a stake of 250 shares — an estimated $77K sold.

Edmond de Rothschild (Europe) first reported a position in BIIB in Q2 2015 and held it in 3 quarters. The position peaked at $101K in Q2 2015. 947 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • Edmond de Rothschild (Europe) reported no remaining Biogen position as of Q1 2016 after selling out during the quarter.
  • Edmond de Rothschild (Europe) sold 250 Biogen shares in Q1 2016, an estimated $77K.
  • Edmond de Rothschild (Europe) first reported a position in Biogen in Q2 2015 and held it in 3 quarters.
  • Edmond de Rothschild (Europe)'s Biogen position peaked at $101K in Q2 2015.
  • 947 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Edmond de Rothschild (Europe)'s 13F filing for Q1 2016, filed 12 May 2016.